Health7h agoMoneycontrol

Serum Institute partners with Gates Medical Research to make experimental TB vaccine

in5points

Serum Institute of India partners with Gates Medical Research Institute to manufacture experimental TB vaccine M72/AS01E.
The vaccine candidate has been in development for two decades and is currently in a late-stage clinical trial.
The partnership aims to accelerate production and distribution if the vaccine proves effective.

7h ago · original ↗

Moneycontrol

Center-right

Mixed factuality

Who owns this?

Network18

Reliance Industries (Mukesh Ambani)

Wikipedia: Mukesh Ambani

Coverage spectrum

Left blind spot

Only right-leaning outlets are covering this so far.

Outlet lean

2 sources

-

Left

Center

Right

Compare headlines

Same story, different framing

CenterMoneycontrol
Serum Institute partners with Gates Medical Research to make experimental TB vaccine
The article frames the partnership as a positive development in the fight against tuberculosis, highlighting the collaboration between a major Indian vaccine maker and a global health research institute.
RightAsianet Newsable
Gates MRI, Serum Institute ink deal to make potential new TB vaccine
The story is framed as a positive development in global health, highlighting a collaborative effort to address a major disease.

›

Also covered by

1 outlet

Asianet Newsable6h ago
Gates MRI, Serum Institute ink deal to make potential new TB vaccine